MarketPulse

share price decline

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Adjusts Debenture Terms Amid Share Price Decline

Quantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation.
QNTMwarrantsbiopharmaceutical
The Motley FoolThe Motley Fool··Adé Hennis

UWMC Chief Executes $9M Share Divestment as Holdings Drop Nearly Half

UWMC CEO Mat Ishbia sold 1.9M shares for $9M, cutting his holdings nearly in half. The pre-arranged sale reflects ongoing pressure on the mortgage lender's stock.
UWMCearnings reportinsider sale